Application of ERAS concept in clinical nursing of patients with advanced cancer pain of gynecological malignant tumors

被引:1
|
作者
Liao, Haijing [1 ,2 ]
Lei, Yuanxiu [2 ]
机构
[1] First Peoples Hosp Chenzhou, Gynaecol Area 2, Chenzhou, Hunan, Peoples R China
[2] First Peoples Hosp Chenzhou, Gynaecol Area 1, Chenzhou, Hunan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
cancer pain; ERAS concept; malignant tumor; clinical nursing; clinical; CHRONIC NONCANCER PAIN; ENHANCED RECOVERY; IMPACT;
D O I
10.3389/fonc.2023.1173333
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gynecological malignant tumors refer to malignant tumors of organs and tissues centered on the uterus, ovaries, and fallopian tubes. Among gynecological tumors, endometrial cancer is the most malignant, accounting for more than 80% of malignant tumors in the female reproductive tract. Common symptoms are vaginal bleeding and pain. This article aims to explore the application and analysis of the concept of ERAS (Enhanced Recovery After Surgery) in the clinical care of patients with advanced cancer pain from gynecological malignancies. ERAS aims to reduce complications, shorten hospitalization time, reduce medical costs, and enable patients to recover quickly by adopting a series of perioperative management measures for patients. This article analyzes the pain caused by late-stage cancer, proposes an ERAS multimodal analgesia method, and uses image fusion technology to detect cancer patients. This article finally conducts an experimental exploration of the clinical nursing of the ERAS concept in the treatment of advanced cancer pain in gynecological malignancies. The results of this study showed that in terms of pain impact score, before treatment, the score of group M was 39.07 and the score of group N was 38.92, and the difference was not statistically significant. The score after ERAS concept treatment was 58.14, and the score after traditional treatment was 43.79, with a significant difference. Research shows that the pain impact score after treatment is significantly better than before treatment, and the improvement effect of ERAS concept treatment is more obvious.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] COAGULATION-FACTOR-XIII IN PLASMA OF PATIENTS WITH BENIGN AND MALIGNANT GYNECOLOGICAL TUMORS
    VANWERSCH, JWJ
    PETERS, C
    UBACHS, JMH
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1994, 32 (09): : 681 - 684
  • [22] Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer
    Feuer, DJ
    Broadley, KE
    Shepherd, JH
    Barton, DPJ
    GYNECOLOGIC ONCOLOGY, 1999, 75 (03) : 313 - 322
  • [23] Application of clinical nursing pathway in nursing care of patients undergoing gastric cancer surgery
    Yu, Li
    Ma, Songcui
    Wang, Siqin
    Li, Mei
    MINERVA GASTROENTEROLOGY, 2022, 68 (02): : 249 - 251
  • [25] Pain nursing for gynecologic cancer patients
    Wu, Wei
    He, Xiaodan
    Li, Shenjie
    Jin, Ming
    Ni, Yali
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [26] CLINICAL SIGNIFICANCE OF MR IMAGING IN THE JUDGMENT OF LYMPH NODE METASTASIS IN GYNECOLOGICAL MALIGNANT TUMORS
    Wang, J.
    Tang, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A94 - A95
  • [27] Effects of ERAS combined with holistic nursing in elderly patients with ovarian cancer
    Yu, Xiaolan
    Hu, Die
    Chen, Li
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (02): : 961 - 970
  • [28] The trifunctional antibody catumaxomab: Clinical experience in the treatment of malignant ascites due to gynecological tumors
    Marmé F.
    Der Gynäkologe, 2011, 44 (11): : 917 - 923
  • [29] Clinical Analysis of the Discovery of Malignant Gynecological Tumors in the Diagnosis and Treatment of Pelvic Organ Prolapse
    Niu, Li-Na
    Wang, Jun-Xia
    Li, Xia
    Xu, Yong-Jun
    Qiu, Li-Rong
    Guo, Sheng
    Zhang, Li-Zhen
    Shang, Yun
    FRONTIERS IN SURGERY, 2022, 9
  • [30] Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial
    Kristeleit, Rebecca
    Devlin, Michael-John
    Clamp, Andrew
    Gourley, Charlie
    Roux, Rene
    Hall, Marcia
    Nirsimloo, Rachel
    Kounnis, Valentinos
    Sage, Lesley
    Narayanan, Priya
    Herrington, C. Simon
    Arora, Rupali
    Farrelly, Laura
    Hughes, Laura
    Counsell, Nicholas
    Miller, Rowan E.
    JAMA ONCOLOGY, 2025,